Register free for our breaking news email alerts with analysis and cutting edge commentary from our award winning team. Registration only takes a minute.

Quilter Investors Europe Eq IncU2 GBP Acc

Ranked 116 out of 128 in - Europe Excluding UK over 12 months
All calculations are in GBP unless stated

Managed by

James Sym

James Sym joined Cazenove Capital in 2007. He is a member of the pan-European equity team with responsibility for Chemicals, Support Services, Household Goods, Personal Goods, Pharmaceuticals & Biotechnology and Telecommunication sector coverage. James manages the Schroder European Alpha and Alpha Plus funds. He graduated from St John's College, Cambridge University with a degree in Natural Sciences (Mineral Physics) and Management Studies and is a Chartered Financial Analyst. He has six years of investment experience.

Objective

The Fund aims to achieve income and capital growth. The Fund primarily invests, directly and indirectly, in shares of companies listed or located in Europe, excluding the United Kingdom. The investment adviser typically has a preference to invest in shares of companies they believe are likely to provide dividend payments. The Fund may at times be concentrated in terms of the number of investments it holds. The Fund may also invest in other transferable securities, collective investment schemes (including those managed or operated by the ACD), warrants, money market instruments, deposits and derivatives.

Showing fund performance in United Kingdom View performance globally

Performance

Europe Excluding UK over : 30/04/2018 - 30/04/2019

Total Return

Quarterly Performance

to 31/03/2019 Annual Q1 Q2 Q3 Q4
2019 7.1%
2018 -16.1% -3.8% 4.3% -2.7% -14.0%
2017 4.3% -0.2%

Month by Month Performance

Returns Vs Risk

Asset Allocation

Breakdown

31/03/2019

Top 10 Holdings

Stock Size
Roche Holding AG Par 5.97%
GBP Cash 4.89%
ASML Holding NV ORD 4.74%
Zurich Insurance Group AG ORD 4.61%
AXA SA ORD 4.36%
KBC Groep NV ORD 3.74%
Koninklijke KPN NV ORD 3.64%
Total SA ORD 3.61%
Novo Nordisk A/S ORD 3.32%
Grupo Catalana Occidente SA ORD 3.32%
31/03/2019

Registered For Sale In

  1. United Kingdom

Fund Info

  • Launch date12/04/2017
  • Share Class size101Mn
  • Base currencyGBP
  • ISIN GB00BD4HJ668

Purchase Info

  • Min. initial investment250Mn
  • Min. regular additional investment0

Charges

  • Annual management0.60%
  • Initial investment0.00%

Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in the currency and currencies indicated).